|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
159,210,000 |
Market
Cap: |
1.08(B) |
Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,299 |
52
Week Range: |
$1.78 - $6.34 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Benet Leslie Z |
Director |
|
2014-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,400 |
8,100 |
|
- |
|
Terreri Peter R |
Director |
|
2014-05-13 |
4 |
AS |
$26.70 |
$17,782 |
D/D |
(666) |
41,336 |
|
- |
|
Fleming Nigel |
Director |
|
2014-05-12 |
4 |
S |
$26.58 |
$35,435 |
D/D |
(1,333) |
8,366 |
|
- |
|
Nestor Michael |
President, Impax Pharm. |
|
2014-05-11 |
4 |
D |
$26.52 |
$2,042 |
D/D |
(77) |
86,056 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-08 |
4 |
S |
$26.85 |
$26,850 |
D/D |
(1,000) |
9,699 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-08 |
4 |
OE |
$6.55 |
$6,550 |
D/D |
1,000 |
10,699 |
|
- |
|
Terreri Peter R |
Director |
|
2014-05-07 |
4 |
D |
$26.00 |
$160,758 |
D/D |
(6,183) |
42,002 |
|
- |
|
Terreri Peter R |
Director |
|
2014-05-07 |
4 |
OE |
$21.43 |
$160,725 |
D/D |
7,500 |
48,185 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-07 |
4 |
S |
$26.30 |
$228,143 |
D/D |
(8,649) |
9,699 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-07 |
4 |
OE |
$6.55 |
$168,251 |
D/D |
8,649 |
17,199 |
|
- |
|
Hsu Larry |
Director |
|
2014-05-06 |
4 |
S |
$26.28 |
$5,765,464 |
D/D |
(219,386) |
458,568 |
|
- |
|
Fleming Nigel |
Director |
|
2014-05-06 |
4 |
S |
$26.34 |
$105,360 |
D/D |
(4,000) |
9,699 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-06 |
4 |
S |
$26.48 |
$75,498 |
D/D |
(2,851) |
9,699 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-05-06 |
4 |
OE |
$6.55 |
$18,674 |
D/D |
2,851 |
12,550 |
|
- |
|
Wilkinson George Fred |
Chief Executive Officer |
|
2014-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
525,000 |
525,000 |
|
- |
|
Reasons Bryan M. |
Chief Financial Officer |
|
2014-04-13 |
4 |
D |
$24.55 |
$29,853 |
D/D |
(1,216) |
34,086 |
|
- |
|
Nornhold Jeffrey |
SVP, Technical Operations |
|
2014-04-08 |
4 |
D |
$24.50 |
$56,963 |
D/D |
(2,325) |
62,075 |
|
- |
|
Nornhold Jeffrey |
SVP, Technical OperationsOffic |
|
2014-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,400 |
|
- |
|
Markbreiter Michael |
Director |
|
2014-03-11 |
4 |
S |
$27.54 |
$110,161 |
D/D |
(4,000) |
9,699 |
|
- |
|
Burr Robert L |
Director |
|
2014-01-08 |
4 |
AS |
$24.31 |
$36,465 |
D/D |
(1,500) |
43,825 |
|
- |
|
Burr Robert L |
Director |
|
2013-12-11 |
4 |
AS |
$23.77 |
$35,655 |
D/D |
(1,500) |
45,325 |
|
- |
|
Burr Robert L |
Director |
|
2013-11-13 |
4 |
AS |
$22.98 |
$34,470 |
D/D |
(1,500) |
46,825 |
|
- |
|
Hsu Larry |
President and CEO |
|
2013-10-29 |
4 |
D |
$20.68 |
$37,782 |
I/I |
(1,827) |
144,932 |
|
- |
|
Hsu Larry |
President and CEO |
|
2013-10-28 |
4 |
D |
$20.61 |
$37,654 |
I/I |
(1,827) |
146,759 |
|
- |
|
Hsu Larry |
President and CEO |
|
2013-10-26 |
4 |
D |
$20.47 |
$53,775 |
I/I |
(2,627) |
148,586 |
|
- |
|
531 Records found
|
|
Page 9 of 22 |
|
|